CONFERENCE COVERAGE
American Academy of Allergy Asthma and Immunology
Annual Meeting
- Long-Haul COVID-19 and T-Cell Activation
- COVID-19 Mortality and Asthma, COPD, and ACO
- Biologics and Aspirin-Exacerbated Respiratory Disease
- Biologics in Eosinophilic Asthma: Dupilumab vs Mepolizumab vs Benralizumab
- Respiratory Virus Infections and Pediatric Asthma Exacerbations
- Reducing the Frequency of Ongoing Peanut Oral Immunotherapy in Children
- Do Patients With Antibody Deficiency Benefit From COVID-19 Vaccine?
- Effect of Tezepelumab on Severe Asthma Symptoms in Adults and Adolescents
- Gut Microbiota, Diet, and Allergic Asthma Phenotypes in Children
- Peanut Oral Immunotherapy in Children Evaluated via Real World Study
- Omalizumab for Asthma in Children With High Pretreatment Serum IgE Levels
- Airborne Toxicants, Inflammation, and Immune Response in Asthma and COPD
Latest Tweets
Follow
@PulmAdvisor
Conference Coverage from
